AIkido Pharma Depreciation & Amortization 2011-2026 | AIKI

Annual Depreciation & Amortization AIkido Pharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
105 K	105 K	83 K	-	-	-	-	38 K	3 K	2.59 M	1.09 K	402	24 K	63.7 K	69.8 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.59 M	402	280 K

Quarterly Depreciation & Amortization AIkido Pharma

2025-Q3	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	26 K	-	-	-	7 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	21 K	17 K	1 K	-	1 K	343 K	1 K	-	1 K	1 K	-531 K	-	1 K	1 K	-	-	2.48 M	2.45 M	-	-	3 K	5 K	16.1 K	-	50.9 K	33.9 K	15.9 K	-	52.9 K	36.1 K	19 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
2.48 M	-531 K	210 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Coherus BioSciences CHRS	1.3 M	$ 1.63	-4.4 %	$ 191 M	USA
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Enlivex Therapeutics Ltd. ENLV	546 K	$ 0.73	-0.03 %	$ 33.4 M	Israel
Arcturus Therapeutics Holdings ARCT	3.02 M	$ 7.83	-5.21 %	$ 214 M	Israel
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Esperion Therapeutics ESPR	105 K	$ 3.12	-	$ 649 M	USA
Exelixis EXEL	29.1 M	$ 51.1	-0.37 %	$ 13.9 B	USA
Forte Biosciences FBRX	64 K	$ 23.96	-2.84 %	$ 310 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
Karyopharm Therapeutics KPTI	296 K	$ 8.9	0.56 %	$ 1.08 M	USA
AbCellera Biologics ABCL	18.4 M	$ 4.4	-7.76 %	$ 1.31 B	Canada
Amphastar Pharmaceuticals AMPH	31.6 M	$ 17.3	-5.57 %	$ 809 M	USA
Compugen Ltd. CGEN	461 K	$ 3.03	6.32 %	$ 283 M	Israel
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Gilead Sciences GILD	370 M	$ 132.06	-0.74 %	$ 164 B	USA
Genprex GNPX	6.69 K	$ 0.86	1.2 %	$ 802 K	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.49	-4.12 %	$ 5.75 M	Israel
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Fortress Biotech FBIO	403 K	$ 2.3	3.14 %	$ 64.2 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 21.57	-0.55 %	$ 2.74 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA